Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01240694
Show Display Options
Rank Status Study
1 Terminated A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Lupuzor

Study has passed its completion date and status has not been verified in more than two years.